logo
[breadcrumb_custom]

Tag: GTHX Shares

Industry

G1 Therapeutics Inc: A Year of Highs, Lows, and Market Resilience

The market performance of G1 Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $5.00 on 02/08/24, with the lowest value for the same timeframe being $1.08, recorded on 10/09/23. 52-week price history of GTHX Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. G1 Therapeutics Inc’s current trading price is -14.40% away from its 52-week high, while its distance from the 52-week low is 296.30%. The stock’s price range for this period has

CROX
News

G1 Therapeutics Inc (GTHX) Stock: A Year of Stock Market Dynamics

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. G1 Therapeutics Inc’s current trading price is -26.00% away from its 52-week high, while its distance from the 52-week low is 242.59%. The stock’s price range for this time frame has been between $1.08 and $5.00. The trading volume of the company’s shares in the Healthcare reached around 0.98 million for the day, which was evidently lower than the average daily volume of 1.46 million over the last three months. The stock market performance of G1 Therapeutics Inc has

CSCO Stock
News

G1 Therapeutics Inc (GTHX) Stock: A Year of Market Fluctuations

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. G1 Therapeutics Inc’s current trading price is -37.60% away from its 52-week high, while its distance from the 52-week low is 188.89%. The stock’s price range during this period has varied between $1.08 and $5.00. The company, active in the Healthcare sector, saw a trading volume of around 0.55 million for the day, considerably lower average daily volume of 1.54 million observed over the last three months. The stock market performance of G1 Therapeutics Inc